Name	PRICE	MARKET CAPITALIZATION	PRICE TO EARNINGS RATIO	DIVIDEND YIELD	SYMBOL	EXCHANGE	PRICE PERCENT DIFFERENCE	YEAR TO DATE PRICE PERCENT DIFFERENCE	5 YEAR CHART	1 YEAR CHART
AbbVie is a drug company with a strong exposure to immunology and oncology. The company's top drug, Humira, represents over half of the company's current profits. The company was spun off from Abbott in early 2013. http://www.abbvieinvestor.com ABBV $79.76 -1.48 (-1.82%) Sector Health Care Industry Biotech & Pharma Market Cap 119.84 Billion EPS -1.14 P/E Ratio 21.79 Previous Earnings Fri, Nov 2, 2018 Latest Earnings Fri, Jan 25, 2019 Dividend 5.37% / $4.28 Ex-Date Fri, Apr 12, 2019 Dividend Pay Date Wed, May 15, 2019 Dividend History 26 Payments (Quarterly) Note about ABBV $100+ Billion Market Cap sp 500 dividend aristocrats	79.76	119.84	21.79	5.37	ABBV	NYSE	-1.82	-10.61	https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ABBV&exchange=NYSE&chart=5	https://www.symbolsurfing.com/charts/stock_price_chart.php?user_id=true&symbol=ABBV&exchange=NYSE&chart=1